EUVIMED · CrossrefZeitschrift
Endocrine Oncology
ISSN 2634-4793 · Bioscientifica
Neueste Artikel
Diagnostic Utility and Cost Analysis of Sequential TF Immunohistochemistry in Hormone-Immunonegative Pituitary Adenomas
Germline pathogenic variants in succinate dehydrogenase genes: implications from a single-institution study
Geographic variation in diagnosis, treatment, and outcomes of adrenocortical carcinoma in the Americas: a narrative review
Mahvash disease: a novel case of apparent monoallelic disease and a novel cause of hypoglycaemia
Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomas
Unmasking insulinoma following commencement of somatostatin analogues in malignant neuroendocrine tumours
Epidemiological insights and survival patterns in neuroendocrine neoplasia: a geographic perspective
Variable GLP-1 receptor expression across diverse neuroendocrine neoplasms: implications for incretin therapies
Distinguishing neuroendocrine tumor grade 3 from neuroendocrine carcinoma in gastroenteropancreatic high-grade neoplasms
NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations
Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma
The role of 11-oxygenated androgens in prostate cancer
Kinase inhibitors in thyroid cancers
Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?
Acknowledgement to reviewers
The expanding role of hormones in cancer
FOXE1 polymorphism rs965513 predisposes to thyroid cancer in a European cohort
Serum osteopontin can improve papillary thyroid cancer risk assessment of Bethesda III thyroid nodules: a preliminary study
Epidemiology of craniopharyngiomas: a population-based study in Malta
SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients
Investigating the clinical, pathological and molecular profile of oncocytic adrenocortical neoplasms: a case series and literature review
cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome
Hypoxia stimulates angiogenesis and a metabolic switch in human parathyroid adenoma cells
Characterization of hyperlipidemia secondary to mitotane in adrenocortical carcinoma
Potential pitfalls in diagnosis of immunotherapy-induced hypothalamic–pituitary–adrenal axis abnormalities: a clinical case
Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing’s disease
Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding
Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?
Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma
EUVIMED